| [1] |
.
[J]. CLINICAL FOCUS, 2013, 28(6): 675-676.
|
| [2] |
.
[J]. CLINICAL FOCUS, 2013, 28(6): 605-609.
|
| [3] |
.
[J]. Clinical Focus, 2013, 28(5): 543-545.
|
| [4] |
XIANG Li-li;ZHOU Zhi-lan;GU Wei-ying;WANG Zhi-lin;QIU Guo-qiang;CAO Xiang-shan.
Clinical and laboratory features of hematologic malignancies with Y chromosome loss--report of eight cases
[J]. CLINICAL FOCUS, 2013, 28(3): 282-0.
|
| [5] |
.
[J]. Clinical Focus, 2012, 27(22): 2002-0.
|
| [6] |
LI Zhen-hua;LIU Shi-chao;MU Feng-ping.
Serum levels of hepatocyte growth factor and vascular endothelial growth factor and clinical significance in patients with acute leukemia
[J]. CLINICAL FOCUS, 2010, 25(11): 939-942.
|
| [7] |
.
[J]. CLINICAL FOCUS, 2010, 25(9): 742-746.
|
| [8] |
.
[J]. CLINICAL FOCUS, 2010, 25(4): 318-319.
|
| [9] |
AI Li-mei;PAN Jing;MAO Shu-dan;SUN Yuan-yuan.
Melphalan-prednisone-thalidomide applied in elder multiple myeloma as first-line treatment
[J]. CLINICAL FOCUS, 2010, 25(3): 207-209.
|
| [10] |
.
[J]. CLINICAL FOCUS, 2009, 24(24): 2147-2148.
|
| [11] |
.
[J]. CLINICAL FOCUS, 2009, 24(9): 739-742.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2009, 24(5): 435-436.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2009, 24(5): 437-438.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2008, 23(22): 1623-1624.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2008, 23(19): 1400-1401.
|
